CF
PFE icon

Corebridge Financial’s Pfizer PFE Stock Holding History

Corebridge Financial’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-1,263,938
Closed -$32M – 2007
2025
Q1 		$32M Sell
1,263,938
-38,513
-3% -$1.01M 0.18% 81
2024
Q4 		$34.6M Sell
1,302,451
-62,333
-5% -$1.69M 0.19% 77
2024
Q3 		$39.5M Sell
1,364,784
-39,515
-3% -$1.15M 0.21% 66
2024
Q2 		$39.3M Buy
+1,404,299
New +$38.7M 0.22% 65

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Corebridge Financial's PFE Position: Q2 2025 in Review

Corebridge Financial sold out of Pfizer (PFE) in Q2 2025, closing a stake of 1,263,938 shares — an estimated $32M sold.

Corebridge Financial first reported a position in PFE in Q2 2024 and held it in 4 quarters. The position peaked at $39.5M in Q3 2024. 2,810 funds tracked by Wall St. Rank hold PFE as of Q2 2025.

  • Corebridge Financial reported no remaining Pfizer position as of Q2 2025 after selling out during the quarter.
  • Corebridge Financial sold 1,263,938 Pfizer shares in Q2 2025, an estimated $32M.
  • Corebridge Financial first reported a position in Pfizer in Q2 2024 and held it in 4 quarters.
  • Corebridge Financial's Pfizer position peaked at $39.5M in Q3 2024.
  • 2,810 funds tracked by Wall St. Rank held Pfizer as of Q2 2025.

Based on Corebridge Financial's 13F filing for Q2 2025, filed 12 Aug 2025.